Literature DB >> 17828508

Effects of metallothionein on isolated rat heart.

Zhongdong Sun1, Jiahong Xia, Nianguo Dong, Xinling Du, Yifan Chi, Tienan Yang, Chenyuan Yang.   

Abstract

To investigate the effects of metallothionein (MT) on isolated rat heart, 16 Wistar rats were randomly divided into 2 groups. In control group (group C), distilled water was injected intraperitoneally and 24 h later isolated hearts were perfused with Langendorff and stored at 4 degrees C for 3 h with histidine-tryptophan-ketoglutarate (HTK) solutions, and then isolated hearts were perfused for 2 h by Langendorff. In experimental group (group E), 3.6% ZnSO(4) was injected intraperitoneally, 24 h later isolated hearts were perfused by Langendorff and stored at 4 degrees C for 3 h with HTK solutions, and then the isolated hearts were perfused for 2 h with Langendorff. MT content, the recovery of hemodynamics, myocardial water content (MWC), lactate dehydrogenase (LDH) and creatine kinase (CK) leakage, adenosine triphosphate (ATP) and malondialdehyde (MDA) content, superoxide dismutase (SOD) activity, myocardial cell Ca(2+) content, Ca(2+)-ATPase activity of mitochondria ([Ca(2+)-ATPase](m)) and its Ca(2+) content ([Ca(2+)](m)), synthesizing ATP activity of mitochondria ([ATP](m)), and the ultrastructure of cells were examined. There were a significant increase in group E in hemodynamic recovery, ATP content, SOD activity, [Ca(2+)-ATPase](m) activity, [ATP](m) activity, and substantial reduction in MWC, LDH and CK leakage, MDA content, myocardial cell Ca(2+) content, [Ca(2+)](m) content, and the ultrastructural injury were obviously milder than that of group C. This study demonstrated that MT has protective effects on isolated rat heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828508     DOI: 10.1007/s11596-007-0425-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

1.  Mitochondrial oxygen consumption is synergistically inhibited by metallothionein and calcium.

Authors:  C Simpkins; S Balderman; E Mensah
Journal:  J Surg Res       Date:  1998-11       Impact factor: 2.192

2.  Zn(2+) induces stimulation of the c-Jun N-terminal kinase signaling pathway through phosphoinositide 3-Kinase.

Authors:  S J Eom; E Y Kim; J E Lee; H J Kang; J Shim; S U Kim; B J Gwag; E J Choi
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

3.  Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues.

Authors:  D L Eaton; B F Toal
Journal:  Toxicol Appl Pharmacol       Date:  1982-10       Impact factor: 4.219

4.  Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.

Authors:  G W Wang; J B Klein; Y J Kang
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

5.  Metallothionein: localization in human transplant endomyocardium, relation to cytokines and allograft function.

Authors:  H A Baba; K W Schmid; A Takeda; T Wichter; R Gradaus; M Erren; G Plenz; F Grabellus; T D Tjan; M C Deng
Journal:  J Heart Lung Transplant       Date:  1999-10       Impact factor: 10.247

6.  Metallothionein acts as a cytoprotectant against doxorubicin toxicity.

Authors:  T Kimura; I Fujita; N Itoh; N Muto; T Nakanishi; K Takahashi; J Azuma; K Tanaka
Journal:  J Pharmacol Exp Ther       Date:  2000-01       Impact factor: 4.030

7.  Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels.

Authors:  G W Wang; Y J Kang
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.